Margaret Chan, Director-General of the World Health Organization (WHO), addresses the General Assembly.
Margaret Chan, Director-General of the World Health Organization (WHO), addresses the General Assembly during the thirtieth special session in New York, 19 April 2016. UN Photo/Manuel Elias

30th Special Session of the General Assembly on the World Drug Problem, 19-21 April 2016, New York


Reviewing progress on the Plan of Action

Heads of State and Government, ministers and representatives of Member States, assembled at United Nations Headquarters from 19 to 21 April 2016 for the 30th special session of the General Assembly, convened to review the progress in the implementation of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem of 2009, including an assessment of the achievements and challenges in countering the world drug problem, within the framework of the three international drug control conventions and other relevant United Nations instruments. At the Special Session, UN Member States reaffirmed their commitment to the goals and objectives of the three international drug control conventions, including concern about the health and welfare of humankind as well as the individual and public health-related, social and safety problems resulting from the abuse of narcotic drugs and psychotropic substances, in particular among children and young people, and drug-related crime, and reaffirmed their determination to prevent and treat the abuse of such substances and prevent and counter their illicit cultivation, production, manufacturing and trafficking. 

All nations were encouraged to keep in mind the key principles of the 2030 Agenda for Sustainable Development and to leave no one behind. The Special Session resulted in an outcome document, Our joint commitment to effectively addressing and countering the world drug problem.